TABLE 2.

Distribution of radioactivity in pooled urine samples from six healthy male subjects 48 h after intravenous administration of 10 mg/kg [¹⁴C]telavancin

Analyte	Retention time (min)	% of total administered dosea	Metabolite distribution (% analyte in recovered dose)a
Telavancin	42.7	60.4 ± 7.2	82.3 ± 7.4
THRX-651540 or M3 (7-OH)	27.8	6.45 ± 2.37	8.88 ± 3.58
M2 (8-OH)	26.9	3.12 ± 1.27	4.31 ± 1.95
M1 (9-OH)	26.6	3.23 ± 1.25	4.46 ± 1.90
All		73.2 ± 3.8	100

^aValues are mean ± SD.